According to Intercept Pharmaceuticals 's latest financial reports the company's total assets are $0.39 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.55 B | 5.06% |
2021-12-31 | $0.52 B | -9.21% |
2020-12-31 | $0.58 B | -23.1% |
2019-12-31 | $0.75 B | 48.26% |
2018-12-31 | $0.50 B | 5.12% |
2017-12-31 | $0.48 B | -34.48% |
2016-12-31 | $0.73 B | 12.73% |
2015-12-31 | $0.65 B | 158.02% |
2014-12-31 | $0.25 B | 69.07% |
2013-12-31 | $0.15 B | 34% |
2012-12-31 | $0.11 B | 476.15% |
2011-12-31 | $19.47 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Eli Lilly LLY | $64.00 B | 16,179.88% | ๐บ๐ธ USA |
Gilead Sciences GILD | $62.12 B | 15,701.37% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $95.15 B | 24,103.51% | ๐บ๐ธ USA |
MediciNova MNOV | $66.27 M | -83.14% | ๐บ๐ธ USA |